N-homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer's disease and vascular dementia.


Journal

The Journal of pathology
ISSN: 1096-9896
Titre abrégé: J Pathol
Pays: England
ID NLM: 0204634

Informations de publication

Date de publication:
07 2019
Historique:
received: 01 08 2018
revised: 10 01 2019
accepted: 04 02 2019
pubmed: 9 2 2019
medline: 9 4 2020
entrez: 9 2 2019
Statut: ppublish

Résumé

The pathomechanisms that associate a deficit in folate and/or vitamin B12 and the subsequent hyperhomocysteinemia with pathological brain ageing are unclear. We investigated the homocysteinylation of microtubule-associated proteins (MAPs) in brains of patients with Alzheimer's disease or vascular dementia, and in rats depleted in folate and vitamin B12, Cd320 KO mice with selective B12 brain deficiency and H19-7 neuroprogenitors lacking folate. Compared with controls, N-homocysteinylated tau and MAP1 were increased and accumulated in protein aggregates and tangles in the cortex, hippocampus and cerebellum of patients and animals. N-homocysteinylation dissociated tau and MAPs from β-tubulin, and MS analysis showed that it targets lysine residues critical for their binding to β-tubulin. N-homocysteinylation increased in rats exposed to vitamin B12 and folate deficit during gestation and lactation and remained significantly higher when they became 450 days-old, despite returning to normal diet at weaning, compared with controls. It was correlated with plasma homocysteine (Hcy) and brain expression of methionine tRNAsynthetase (MARS), the enzyme required for the synthesis of Hcy-thiolactone, the substrate of N-homocysteinylation. Experimental inactivation of MARS prevented the N-homocysteinylation of tau and MAP1, and the dissociation of tau and MAP1 from β-tubulin and PSD95 in cultured neuroprogenitors. In conclusion, increased N-homocysteinylation of tau and MAP1 is a mechanism of brain ageing that depends on Hcy concentration and expression of MARS enzyme. Its irreversibility and cumulative occurrence throughout life may explain why B12 and folate supplementation of the elderly has limited effects, if any, to prevent pathological brain ageing and cognitive decline. Copyright © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Identifiants

pubmed: 30734924
doi: 10.1002/path.5254
doi:

Substances chimiques

tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

291-303

Informations de copyright

Copyright © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Auteurs

Carine Bossenmeyer-Pourié (C)

Inserm U1256, Nutrition-Genetics and Environmental Exposure, Medical Faculty, University Hospital Center, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

A David Smith (AD)

OPTIMA, Department of Pharmacology, University of Oxford, Oxford, UK.

Sylvain Lehmann (S)

Laboratoire de Biochimie-Protéomique Clinique - IRMB - CCBHM - Inserm U1183, CHU Montpellier, Hôpital St-Eloi - Université Montpellier, Montpellier, France.

Vincent Deramecourt (V)

Inserm U837, Jean-Pierre Aubert Research Centre and Université de Lille Nord de France, Lille, France.

Bernard Sablonnière (B)

Inserm U837, Jean-Pierre Aubert Research Centre and Université de Lille Nord de France, Lille, France.

Jean-Michel Camadro (JM)

Mass Spectrometry Laboratory, Institut Jacques Monod, UMR 7592, Université Paris Diderot, Paris, France.

Grégory Pourié (G)

Inserm U1256, Nutrition-Genetics and Environmental Exposure, Medical Faculty, University Hospital Center, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

Racha Kerek (R)

Inserm U1256, Nutrition-Genetics and Environmental Exposure, Medical Faculty, University Hospital Center, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

Deborah Helle (D)

Inserm U1256, Nutrition-Genetics and Environmental Exposure, Medical Faculty, University Hospital Center, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

Remy Umoret (R)

Inserm U1256, Nutrition-Genetics and Environmental Exposure, Medical Faculty, University Hospital Center, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

Rosa-Maria Guéant-Rodriguez (RM)

Inserm U1256, Nutrition-Genetics and Environmental Exposure, Medical Faculty, University Hospital Center, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

Valérie Rigau (V)

Laboratoire de Biochimie-Protéomique Clinique - IRMB - CCBHM - Inserm U1183, CHU Montpellier, Hôpital St-Eloi - Université Montpellier, Montpellier, France.

Audrey Gabelle (A)

Laboratoire de Biochimie-Protéomique Clinique - IRMB - CCBHM - Inserm U1183, CHU Montpellier, Hôpital St-Eloi - Université Montpellier, Montpellier, France.

Jeffrey M Sequeira (JM)

Department of Medicine, SUNY Downstate Medical Center, New York, NY, USA.

Edward V Quadros (EV)

Department of Medicine, SUNY Downstate Medical Center, New York, NY, USA.

Jean-Luc Daval (JL)

Inserm U1256, Nutrition-Genetics and Environmental Exposure, Medical Faculty, University Hospital Center, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

Jean-Louis Guéant (JL)

Inserm U1256, Nutrition-Genetics and Environmental Exposure, Medical Faculty, University Hospital Center, Université de Lorraine, Vandoeuvre-lès-Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH